Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tailoring follow-up endoscopy in patients with severe oesophagitis.
Grant RK, Brindle WM, Taylor CL, Rycroft EJ, Oyewole O, Morgan SC, Watson EF, Anand A, McAvoy NC, Penman ID, Church NI, Trimble KC, Noble CL, Plevris JN, Masterton GSM, Kalla R. Grant RK, et al. Among authors: morgan sc. Frontline Gastroenterol. 2023 Nov 2;15(2):117-123. doi: 10.1136/flgastro-2023-102485. eCollection 2024 Mar. Frontline Gastroenterol. 2023. PMID: 38486669 Free PMC article.
No-biopsy strategy for coeliac disease is applicable in adult patients: a 'real-world' Scottish experience.
Hoyle A, Gillett P, Gillett HR, Borg R, Nottley S, Farrow S, Elgoweini M, Elhassan M, Fletcher J, Whannel G, Gracie E, Morgan S, Jafferbhoy H, Dunbar L, Reid G, Metcalfe EL, Smith G, Harris S, Robertson C, Thomas M, Younger H, Furrie E. Hoyle A, et al. Frontline Gastroenterol. 2022 Aug 11;14(2):97-102. doi: 10.1136/flgastro-2022-102254. eCollection 2023. Frontline Gastroenterol. 2022. PMID: 36818788 Free PMC article.
Reflecting real-world patients with mesothelioma in research: an interim report of baseline characteristics from the ASSESS-meso cohort.
Conway RJH, Smith N, Cooper W, Lynch G, Patole S, Symonds J, Edey A, Maskell NA, Bibby AC; ASSESS-meso Collaborative group 4; ASSESS-meso Collaborative group. Conway RJH, et al. ERJ Open Res. 2023 Dec 27;9(6):00467-2023. doi: 10.1183/23120541.00467-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 38174143 Free PMC article.
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical Trial.
Roy S, Malone S, Wing K, Chowdhury S, Kishan AU, Sun Y, Wallis CJD, Mohamad O, Jia AY, Swami U, Zaorsky NG, Morgan SC, Ong M, Agarwal N, Spratt DE, Small EJ, Saad F. Roy S, et al. Among authors: morgan sc. JAMA Netw Open. 2024 Oct 1;7(10):e2439434. doi: 10.1001/jamanetworkopen.2024.39434. JAMA Netw Open. 2024. PMID: 39405060 Free PMC article. Clinical Trial.
Metabolic, cardiac, and bone health testing in patients with prostate cancer on androgen-deprivation therapy: A population-based assessment of adherence to therapeutic monitoring guidelines.
Mousa A, Nguyen DD, Lalani AK, Satkunasivam R, Aminoltejari K, Hird A, Roy S, Morgan SC, Malone S, Kokorovic A, Lavallée LT, Huynh M, Shayegan B, Jiang DM, Gotto G, Breau RH, Kulkarni GS, Zlotta A, Wallis CJD. Mousa A, et al. Among authors: morgan sc. Cancer. 2025 Jan 1;131(1):e35606. doi: 10.1002/cncr.35606. Epub 2024 Oct 13. Cancer. 2025. PMID: 39396120 Free PMC article.
Prediction of prostate cancer recurrence after radiotherapy using a fused machine learning approach: Utilizing radiomics from pretreatment T2W MRI images with clinical and pathological information.
Piran Nanekaran N, Felefly TH, Schieda N, Morgan SC, Mittal R, Ukwatta E. Piran Nanekaran N, et al. Among authors: morgan sc. Biomed Phys Eng Express. 2024 Oct 1. doi: 10.1088/2057-1976/ad8201. Online ahead of print. Biomed Phys Eng Express. 2024. PMID: 39353461
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium.
Ong WL, Romero T, Roy S, Nikitas J, Joseph D, Zapatero A, Malone S, Morgan SC, Steinberg ML, Valle LF, Zaorsky NG, Martin Ma T, Rettig MB, Nickols N, Jiang T, Reiter RE, Eleswarapu SV, Maldonado X, Sun Y, Nguyen PL, Millar JL, Martin JM, Spratt DE, Kishan AU; MARCAP Consortium Investigators. Ong WL, et al. Among authors: morgan sc. Eur Urol. 2025 Jan;87(1):49-57. doi: 10.1016/j.eururo.2024.09.009. Epub 2024 Sep 20. Eur Urol. 2025. PMID: 39304428
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial.
Roy S, Saad F, Sun Y, Malone S, Spratt DE, Kishan AU, Wallis CJD, Jia AY, Mohamad O, Swami U, Ong M, Agarwal N, Chowdhury S, Morgan SC. Roy S, et al. Among authors: morgan sc. Eur J Cancer. 2024 Nov;211:114197. doi: 10.1016/j.ejca.2024.114197. Epub 2024 Jun 27. Eur J Cancer. 2024. PMID: 39243730 Clinical Trial.
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial.
Roy S, Sun Y, Chi KN, Ong M, Malone S, Wallis CJD, Kishan AU, Malone J, Swami U, Gebrael G, Brown JR, Jia AY, Morgan SC, Saad F, Chowdhury S, Agarwal N, Spratt DE. Roy S, et al. Among authors: morgan sc. J Urol. 2024 Nov;212(5):672-681. doi: 10.1097/JU.0000000000004158. Epub 2024 Jul 26. J Urol. 2024. PMID: 39058790 Clinical Trial.
109 results